...
机译:Raf抑制剂PLX8394选择性地破坏BRAF二聚体和RAS独立的BRAF-突变的信号传导
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Med 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Med 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Plexxikon Inc Berkeley CA USA;
Plexxikon Inc Berkeley CA USA;
Plexxikon Inc Berkeley CA USA;
NYU Coll Arts &
Sci Ctr Neural Sci New York NY USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Ctr Nacl Invest Oncol Mol Oncol Programme Madrid Spain;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Med 1275 York Ave New York NY 10021 USA;
Plexxikon Inc Berkeley CA USA;
Mem Sloan Kettering Canc Ctr Program Mol Pharmacol 1275 York Ave New York NY 10021 USA;
机译:Raf抑制剂PLX8394选择性地破坏BRAF二聚体和RAS独立的BRAF-突变的信号传导
机译:RAF709的抗肿瘤性质,由突变RAS或BRAF驱动的肿瘤中的RAF激酶二聚体的高选择性和有效的抑制剂
机译:下一代选择性RAF抑制剂对BRAF剪接变异体信号的抑制作用
机译:黑色瘤中BRAF均含量抗性的机制抑制剂抗性
机译:RAF抑制剂PLX8394选择性破坏BRAF-二聚体和不依赖RAS的BRAF突变体驱动的信号传导
机译:RAF抑制剂用野生型BRAF将RAF二聚体和ERK信号传递转椎体